| |
| |
Who will benefit from Anastrozole? |
10 December 2004 |
|
 |
New breast cancer drug
Research findings announced at the San Antonio Breast Cancer Symposium in Texas this week show that a class of drugs called Anastrozole can cut the rate of recurrence of breast cancer by 76 per cent, with fewer side effects than the drug that is currently used, Tamoxifen.
Martha asks Delyth Morgan, Chief Executive of Breakthrough Breast Cancer,what the new drugs do, who will benefit and when they will be available to women in the UK?
Breakthrough Breast CancerDisclaimer
The BBC is not responsible for the content of external websites. |
| |
|
|
Retired? Downsizing? Moving home to be nearer the kids?We'd like to hear your stories about moving house |
